Zimmer upgraded to Buy from Neutral at Summer Street Summer Street upgraded Zimmer to Buy with a $133 price target citing the proposed acquisition of Biomet. The firm recommends using any weakness from the Q2 earnings report as a buying opportunity.
BIOLASE CEO Jeffrey Nugent to step down, Harold Flynn appointed CEO BIOLASE (BIOL) announced that Harold Flynn Jr. will become president and CEO, effective July 13. The current president and CEO Jeffrey Nugent will step down at that time. Since 2007, Flynn has been president of Zimmer Dental, a manufacturer and provider of medical devices for the dental market. Zimmer Dental is a division of Zimmer Holdings (ZMH).